Broadwater Capital’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$866K Hold
9,450
0.63% 33
2026
Q1
$747K Hold
9,450
0.56% 40
2025
Q4
$747K Hold
9,450
0.56% 40
2025
Q3
$755K Sell
9,450
-849,555
-99% -$72.5M 0.55% 40
2025
Q2
$859M Buy
859,005
+849,555
+8,990% +$77.6M 0.67% 36
2025
Q1
$885K Hold
9,450
0.69% 38
2024
Q4
$859K Hold
9,450
0.66% 38
2024
Q3
$981K Hold
9,450
0.72% 39
2024
Q2
$917K Hold
9,450
0.71% 39
2024
Q1
$851K Sell
9,450
-650
-6% -$55.1K 0.65% 40
2023
Q4
$805K Buy
+10,100
New +$759K 0.63% 41

Other funds holding CL

Broadwater Capital's CL Position: Q2 2026 in Review

Broadwater Capital held its Colgate-Palmolive (CL) position steady in Q2 2026 at 9,450 shares worth $866K. The position accounts for 0.63% of the portfolio, ranked #33.

Broadwater Capital first reported a position in CL in Q4 2023 and has held it in 11 quarters since. The position peaked at $859M in Q2 2025. 1,098 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Broadwater Capital held 9,450 shares of Colgate-Palmolive worth $866K as of Q2 2026.
  • Broadwater Capital left its Colgate-Palmolive share count unchanged in Q2 2026.
  • Colgate-Palmolive made up 0.63% of Broadwater Capital's portfolio in Q2 2026, its #33 holding.
  • Broadwater Capital first reported a position in Colgate-Palmolive in Q4 2023 and has held it in 11 quarters since.
  • Broadwater Capital's Colgate-Palmolive position peaked at $859M in Q2 2025.
  • 1,098 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Broadwater Capital's 13F filing for Q2 2026, filed 24 Jul 2026.